Intraductal papillary mucinous neoplasm in an annular. Intraductal papillary mucinous neoplasms are tumors neoplasms that grow within the pancreatic ducts intraductal characterized by the production of thick fluid by the tumor cells mucinous. The etiology is unknown, but increasing evidence suggests the involvement of several tumorigenesis pathways. Non mucinous pancreatic cysts primarily include serous cyst adenomas scas as well as cystic variants of solid lesions such as solid pseudopapillary tumors and pancreatic neuroendocrine tumors. Intraductal papillary mucinous neoplasms of the pancreas are a spectrum of neoplasms with varying grades of dysplasia and epithelial types 1, 2. Intraductal papillary mucinous neoplasm ipmn of the pancreas with low grade dysplasia, also referred to as ipmn adenoma, is not reportable. The incidence of intraductal papillary mucinous neoplasms ipmns has been increasing over the past decade, mainly owing to increased awareness and the increased use of crosssectional imaging. It is a benign or lowgrade neoplasm associated with a dilated main pancreatic duct, patulous ampullary orifice, and abundant mucus secretion. Enhanced computed tomography revealed a multilocular cystic mass in the distal body and tail of the pancreas. Intraductal papillary mucinous neoplasm in an annular pancreas. Metachronous intraductal papillary mucinous neoplasms. Intraductal papillary mucinous neoplasms ipmn are cystic neoplasms with the potential for progression to.
Branch duct intraductal papillary mucinous neoplasm bdipmn. Less is known about the epithelial subtypes of the precursor ipmn from which these lesions arise. Intraductal papillary mucinous neoplasms basicmedical key. Intraductal papillary mucinous neoplasms sciencedirect. In this issue of jama surgery, hu and colleagues 1 examined the question of early resection vs continued radiologic surveillance for the subset of patients who presented with branch duct intraductal papillary mucinous neoplasms with worrisome features, using markov modeling for comparative effectiveness. Intraductal papillary mucinous neoplasm ipmn of the pancreas is a grossly visible, noninvasive epithelial neoplasm of mucin producing cells arising in the main pancreatic duct or its branches. Intraductal papillary mucinous neoplasm of the biliary tract ipmnb is an increasingly recognized pathologic entity characterized by intraluminal papillary masses and increased mucin secretion, resulting in obstruction and dilation of the biliary tree. Intraductal papillary mucinous neoplasms can be further subdivided into neoplasms that involve the main pancreatic ducts andor those that involve branch ducts. Intraductal papillary mucinous neoplasms listed as ipmn. Kang hj, lee jm, joo i, hur by, jeon jh, jang jy, et al. Intraductal papillary mucinous neoplasms are important because some of them progress to invasive cancer transform from a benign tumor to a malignant. The purpose of this study is to compare the ct features of colloid carcinoma and tubular adenocarcinoma of the pancreas arising in association with intraductal papillary mucinous neoplasms ipmns.
Yamaguchi h, inoue t, eguchi t, et al fascin overexpression in intraductal papillary mucinous neoplasms adenomas, borderline neoplasms, and carcinomas of the pancreas, correlated with increased histological grade. Diabetes mellitus in intraductal papillary mucinous neoplasm. Intraductal papillary mucinous neoplasm ipmn is characterized by enhanced mucus secretion. Chen ry m, cunningham jt, durkalski v, kim ey, patel rs, et al. Intraductal papillary mucinous neoplasm ipmn is a type of tumor that can occur within the cells of the pancreatic duct. Intraductal papillary mucinous neoplasm ipmn of the pancreas is a mucinproducing cystic mass originating from the pancreatic ductal system. Mucinous cystic neoplasms, in contrast, are typically unilocular or multilocular, with a small number of discrete compartments. Cystic neoplasms of the pancreas michigan state university. The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm ipmn. Intraductal papillary mucinous neoplasm of pancreas.
Sahani intraductal papillary and mucinous neoplasms of the. The imaging features of ipmns are derived from the nature of neoplastic cells producing copious mucin. Oncocytic type intraductal papillary mucinous neoplasm of. Pancreatic ductal adenocarcinoma concomitant with intraductal. The prevalence of carcinoma in mainduct intraductal papillary mucinous neoplasm ipmn is high, and surgical resection is recommended for all patients with a mainduct ipmn.
The management of these lesions can be complicated, and we thought it would be helpful if we provided general answers to the most common questions our patients have about intraductal papillary mucinous neoplasms. The chromatin regulator brg1 blocks ipmn formation from adult pancreatic duct cells in the context of oncogenic kras, while brg1 is critical for acinar cell. The aim of this study was to validate these criteria and analyse the outcomes in function of the surgical procedure and ipmn subtype. Intraductal papillary mucinous neoplasm ipmn is a pancreatic cystic lesion originating from intraductal growth of mucin producing cells. Intraductal papillary mucinous neoplasms of the pancreas.
A growing number of patients are being diagnosed with an intraductal papillary mucinous neoplasm ipmn of the pancreas. Aug 02, 2017 the risk for malignant transformation of branch duct intraductal papillary mucinous neoplasms bdipmns is unclear. Pdf intraductal papillary mucinous neoplasm of pancreas. It is a benign or lowgrade neoplasm associated with. Intraductal papillary mucinous neoplasm of the pancreas ipmn was first described in 1982 when four patients with pancreatic carcinoma and favorable outcomes were reported.
A mainduct ipmn with typical imagings including protruding lesions in the dilated main pancreatic duct was resected, but the histology was intraductal papillary mucinous adenoma. Mainduct intraductal papillary mucinous adenoma of the. The sendai and fukuoka consensus guidelines provide us with clinical management guidelines and algorithms. Intraductal papillary mucinous neoplasms ipmns of the pancreas are potentially malignant intraductal epithelial neoplasms that are grossly visible typically 10 mm and are composed of mucinproducing columnar cells. We sought to examine the associations of dm with degree of dysplasia and morphological subtypes in ipmn. The lesions show papillary proliferation, cyst formation, and varying degrees of cellular atypia 1,2.
Management of intraductal papillary mucinous neoplasms. Such is the case of intraductal papillary mucinous neoplasms ipmn in pancreatology. Intraductal papillary mucinous neoplasm radiology reference. In the following years, lesions with similar characteristics were reported. Over the last 20 years, this diagnosis has gradually permeated the thinking of physicians and researchers involved in pancreatic diseases, and suddenly pancreatic symptoms have a broader differential. Intraductal papillary mucinous neoplasms ipmn increasingly recognized similar to mcns cystic tumor that secrete mucin arise from a duct papillary epithelium affect a mostly elderly men. Both benign and malignant tumors of the pancreas are thought to contribute to recurrent pancreatitis possibly by pancreatic duct obstruction, and ipmns contribute to a major share of this. Intraductal papillary mucinous neoplasm ipmn classification of ipmn intraductal papillary mucinous neoplasms are a type of neoplasm that is seen normally growing in the pancreatic ducts. Molecular mechanism of intraductal papillary mucinous. Imaging features to distinguish malignant and benign branchduct type intraductal papillary mucinous neoplasms of the pancreas.
Oncocytic type intraductal papillary mucinous neoplasm is a newly defined subgroup of intraductal papillary mucinous neoplasms. Oncocytic type intraductal papillary mucinous neoplasm. The authors investigate the clinicopathological characteristics and the impact on survival of. Nov 23, 2011 the prevalence of carcinoma in mainduct intraductal papillary mucinous neoplasm ipmn is high, and surgical resection is recommended for all patients with a mainduct ipmn.
The utilization of imaging features in the management of. As such ipmn is viewed as a precancerous condition. Intraductal papillary mucinous neoplasms of the pancreas ipmns are characterised by the presence of dilated and, frequently, cystic pancreatic ducts filled with mucus. However, the most threatening cyst lesions are intraductal papillary mucinous neoplasms. Dhyani pathological subtypes of intraductal papillary. A significant proportion of patients with intraductal papillary mucinous neoplasms ipmns undergo surgical resection in order to. Objective invasive cancers arising from intraductal papillary mucinous neoplasm ipmn are recognised as a morphologically and biologically heterogeneous group of neoplasms. Histopathological subtypes of intraductal papillary mucinous neoplasm ipmn of the pancreas and their typical mucin patterns. Subsequently categorized as having a higher underlying potential for malignancy. A mainduct ipmn with typical imagings including protruding lesions in the dilated main pancreatic duct was resected, but the histology was intraductal papillary mucinous adenoma of the pancreas.
Intraductal papillary mucinous neoplasms ipmns represent a group of cystic pancreatic neoplasms with large range of clinical behaviours, ranging from lowgrade dysplasia or borderline lesions to invasive carcinomas. In the group of cystic neoplasms of the pancreas, the intraductal papillary mucinous tumor ipmn represents a recently characterized entity. Management of intraductal papillary mucinous neoplasms ncbi. Ipmn of the oncocytic type showing positivity for muc5.
At ercp a fishmouthed, open ampulla was demonstrated to exude mucinous content. Ipmn of the pancreatobiliary type positive for muc1. Intraductal papillary mucinous neoplasm ipmn is a benign cystic lesion that grows in the pancreatic ductal system. Apr 22, 2011 mucinous cystic neoplasm of the liver has been a controversial entity, in particular, regarding differentiation from intraductal papillary neoplasm of the bile duct. The world health organization classification separates ipnb into intraductal papillary neoplasm ipn with low or intermediategrade intraepithelial neoplasia, ipn with highgrade intraepithelial neoplasia, and ipn with an associated invasive carcinoma. Pdf intraductal papillary mucinous neoplasms roberto. A 35yearold woman presented complaining of epigastric pain for one month. Associated invasive carcinoma may be identified in 40%60% of resected ipmn lesions with estimated fiveyear.
Pdf intraductal papillary mucinous neoplasm of the pancreas. The european consensus 2018 established a new algorithm with absolute and relative criteria for intraductal papillary mucinous neoplasms of the pancreas ipmn management. Intraductal papillary mucinous neoplasm ipmn is a cystic tumor of the pancreas. Intraductal papillarymucinous neoplasm of the pancreas in. These types of lesions are being increasingly diagnosed partly explained due to the technological advances over the past years. Pancreatic intraductal papillary mucinous neoplasms ipmns are mucinproducing neoplasms with a frequent papillary architecture that arise within the pancreatic ducts and are increasingly being recognised. Intraductal papillary mucinous neoplasm radiology case. Ipmn occurs more commonly in men, with the mean age at diagnosis between 64 and 67 years old. Intraductal papillary mucinous neoplasia ipmn of the. Pathology outlines intraductal papillary mucinous neoplasm.
The treatment options for intraductal papillary mucinous neoplasm of pancreas may vary, depending on the location of the cystic lesion, the grade of ipmn, and whether there is an invasive component to the lesion. Beginning with morphological classification and its clinical significance, natural history, and malignant change of both main duct and. It is now commonly accepted that these tumours can be classified into two main categories according to their origin in the glandthat is main duct ipmn mdipmn and. Intraductal papillary mucinous neoplasm and the pancreatic. Survival after resection for invasive intraductal papillary mucinous neoplasm and for pancreatic adenocarcinoma. Histopathological evaluation of minor salivary gland. In the present study, we observed gross morphologic, histopathologic, and biologic similarities between ipn of the bile duct and intraductal papillary mucinous neoplasm of the pancreas and confirmed previous reports that ipn of the bile duct could be a counterpart to intraductal papillary mucinous neoplasm of the pancreas 18, 29. Adjuvant chemoradiotherapy after pancreatic resection for invasive carcinoma associated with intraductal papillary mucinous neoplasm of the pancreas. Intraductal papillary mucinous tumors of the pancreas. The intraductal papillary mucinous neoplasm cases comprised 227.
Intraductal papillary mucinous neoplasms are one of a number of mucinous tumors of the pancreas and can be further divided both histologically and with respect to their macroscopic appearance 5. Faqs about intraductal papillary mucinous neoplasms ipmns. Intraductal papillary mucinous neoplasms ipmn are mucin producing cystic neoplasms of the pancreas first recognized by the world health organization in 1996. Waters ja, schnelldorfer t, aguilarsaavedra jr, et al. Intraductal papillary mucinous neoplasms or tumors ipmns or impts are epithelial pancreatic cystic tumors of mucinproducing cells that arise from the pancreatic ducts.
Mucinous pancreatic cysts are precursor lesions to invasive pancreatic cancer and comprise of mucinous cystic neoplasm mcn and ipmn. Because they exhibit a spectrum of dysplasia ranging from low grade to high grade and may also have associated invasive carcinoma, and because they. Intraductal papillary mucinous neoplasia ipmn of the pancreas are the subgroup of neoplasms formed by mucinous cells that are located in the. Prognosis of invasive intraductal papillary mucinous. Mucinous cystic neoplasm intraductal papillary mucinous neoplasm patient age year range mean 2776 51 4082 66 patient gender male female 4 21 16% 84% 17 19 47% 53% location of the lesion headneckuncinate body tail 8 3 14 32% 12% 66% 28 6 2 78% 17% 6% size of the lesion cm range mean 1. A new set of guidelines have been formulated for the management of ipmns 1. Assessment of malignant potential in intraductal papillary mucinous neoplasms of the pancreas. Poultsides ga, et al histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm associated invasive adenocarcinoma of the pancreas. Ipmn of the pancreas is reportable when stated as ipmn with highgrade dysplasia, or ipmn with an associated invasive carcinoma, or ipmn with an associated in situ carcinoma. The diagnosis and treatment of intraductal papillary mucinous tumors ipmn of the pancreas has evolved over the last decade. How is intraductal papillary mucinous neoplasm of pancreas treated.
Clinically, the majority of intraductal papillary mucinous neoplasms ipmns of the pancreas show cystic dilation of the branch ducts andor dilation of the main pancreatic duct mpd, particularly marked mpd ectasia in the main duct type, with or without mural nodules. The patients were noted to have dilated main pancreatic ducts, patulous ampullary orifices, and mucus secretion from the pancreatic duct 6. We hypothesized that the development and implementation of guidelines should have increased. Additionally, impn is to be starkly contrasted with adenocarcinoma of the pancreas. Over time, multiple guidelines have been developed to identify highrisk ipmn. Cystforming intraductal papillary neoplasm of the bile ducts. Intraductal papillary mucinous neoplasm without associated invasive carcinoma. Fine needle aspiration diagnosis of mucinous cystic. A suggested mechanistic model of intraductal papillary mucinous neoplasia ipmn and ipmn. While the association between diabetes mellitus dm and pancreatic ductal adenocarcinoma is well recognized, its importance in intraductal papillary mucinous neoplasm of the pancreas ipmn is not welldefined. Backgroundaimsintraductal papillary mucinous neoplasms ipmns are neoplasms of the pancreatic duct epithelium characterized by intraductal papillary growth and thick mucin secretion. They can be grouped into lesions originating from the main pancreatic duct, main duct ipmns mdipmns, and lesions which arise from secondary branches of parenchyma, denominated. On imaging, particularly mrcp, they are characterized by single or multiple unilocular or septated pancreatic cystic lesions communicating with the pancreatic ducts.
Kim kw, park sh, pyo j, yoon sh, byun jh, lee mg, et al. Intraductal growth of neoplastic cells usually forms papillae in a variable extension, although it can rarely be completely flat. The imaging features of ipmns are derived from the nature of neoplastic. Prognostic relevance of morphological types of intraductal. Intraductal papillary mucinous neoplasm of the pancreas. In the current retrospective study, researchers assessed the risk for development of malignancy highgrade dysplasia or invasive neoplasm in 577 patients with suspected or presumed bdipmns.
Cureus intraductal papillary mucinous neoplasm of the. Subbranch and mixedtype intraductal papillary mucinous. Ipmn is a disease of the ductal epithelium and represent a spectrum of disease, ranging from benign to malignant lesions, making the early detection and characterization of these lesions important. Intraductal papillary mucinous neoplasm, ipmn, pancreas, natural history, malignant transformation, cancerogenesis introduction large crosssectional studies using modern abdominal imaging modalities such as magnetic resonance imaging mri or computed tomography ct have shown that approximately 2% of the general population exhibit. Intraductal papillary mucinous neoplasms how is intraductal. Intraductal papillary mucinous neoplasm ipmn of the pancreas is a cystic tumor with a disease spectrum ranging from lowgrade dysplasia to invasive. Cystic lesions of the pancreas are a common entity with almost a 25% incidence of the general population. Pathological features and diagnosis of intraductal papillary. It is illustrated with the production of a thick fluid by the mucinous or tumor cells. Branch duct intraductal papillary mucinous neoplasms. Intraductal papillary mucinous neoplasms ipmns of the pancreas have drawn considerable interest in recent years as we begin to learn more about the natural history of this disease. Dysplasia within these lesions is categorized as low grade, moderate grade and high grade. Oct, 2018 how is intraductal papillary mucinous neoplasm of pancreas treated. Intraductal papillary mucinous neoplasms ipmns are cystic pancreatic tumors that arise from the pancreatic ducts and are increasingly reported worldwide.
In patients with asymptomatic branch duct intraductal papillary mucinous neoplasms or mucinous cystic neoplasms who underwent resection, the prevalence rate of. To evaluate the influence of consensus guidelines on the management of intraductal papillary mucinous neoplasms ipmn and the subsequent changes in pathologic outcomes background. Intraductal papillary mucinous neoplasm ipmn may have distinct pancreatic ductal adenocarcinoma pdac in the same pancreas and the incidence of this has been reported to range from 2. Figure 1 mrcp demonstrating intraductal papillary mucinous neoplasm in the head of the pancreas and uncinate, with dilated main duct 6 mm, and multiple dilated side branches, likely representing mixedtype intraductal papillary mucinous neoplasm. Intraductal papillomas were unilocular cystic lesions with intraluminal papillary growth of. At the time of diagnosis, it may be benign, with or without. While the risk for undergoing malignant transformation is dependent on a number of factors, the risk is certainly present, differentiating it from other cystic lesions of the pancreas. This results in diffuse or segmental dilation of the involved pancreatic ducts without stricture 12. Pancreas intraductal papillary mucinous neoplasm ipmn more common in men, usually between ages 60 70 years hum pathol 2012. Ipmn tumors produce mucus, and this mucus can form pancreatic cysts.
Mucin secreted into the duct often leads to dilation of the main duct and side branches. Intraductal papillary mucinous neoplasms request pdf. Intraductal papillary mucinous neoplasms ipmns represent an opportunity to treat pancreatic tumors before they develop into aggressive, hardtotreat cancers. Although intraductal papillary mucinous neoplasms are benign tumors, they can progress to pancreatic cancer. Intraductal papillary mucinous neoplasm mixed variant. Pdf intraductal papillary mucinous neoplasms of the.
Intraductal papillary mucinous neoplasm of the biliary. The progression of and optimal surveillance intervals for branchduct ipmns bdipmn has not been widely studied. Mucinous cystic neoplasm without associated invasive carcinoma. More methods are needed to help in predicting benign from malignant forms of ipmn. The management of an ipmn once identified is based on clinical settings, age of the patient, cytological examination of aspirated fluid. Cancer of the ovary, papillary serous cystadenocarcinoma. Intraductal papillary mucinous neoplasms as tumor structures are formed in mucinproducing columnar cells of pancreas. They are uncommon ductal epithelial tumors comprising approximately 1015% of cystic pancreatic neoplasms. Quantities of mucin fill the main andor branches of pancreatic.
Thought to be main duct rather then side branch due to the main duct dilatation. Intraductal papillary mucinous neoplasms ipmns of the pancreas are neoplasms that are characterized by ductal dilation, intraductal papillary growth, and thick mucus secretion. Stratifying intraductal papillary mucinous neoplasms by cyst. Most guidelines for management of patients with intraductal papillary mucinous neoplasms ipmn vary in proposed surveillance intervals and durationsthese are usually determined based on expert opinions rather than substantial evidence. Natural history and management of intraductal papillary. Intraductal papillary mucinous neoplasm and acute pancreatitis. Adjuvant therapy in invasive intraductal papillary mucinous. The etiology is unknown, but increasing evidence suggests the involvement of several tumorigenesis pathways, including an association with hereditary syndromes. Every now and then a disease emerges that manages to transform a medical field.